Achmea Investment Management B.V. Pfizer Inc Transaction History

Achmea Investment Management B.V.

$6.87 Billion
Q1 2025

A detailed history of Achmea Investment Management B.V. transactions in Pfizer Inc stock. As of the latest transaction made, Achmea Investment Management B.V. holds 311,902 shares of PFE stock, worth $7.32 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

311,902

Previous 106,016 194.2%

Holding current value

$7.32 Million

Previous $2.81 Million 181.08%

% of portfolio

0.12%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$25.01 - $27.13 $5.15 Million - $5.59 Million	205,886 Added 194.2%	311,902 $7.9 Million
Q4 2024 Feb 10, 2025	BUY	$24.8 - $30.19 $2.63 Million - $3.2 Million	106,016 New	106,016 $2.81 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $3.49 Million - $4 Million	-134,704 Reduced 40.42%	198,587 $5.51 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $6.75 Million - $8.77 Million	-258,413 Reduced 43.67%	333,291 $9.6 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $8.11 Million - $9.48 Million	-252,826 Reduced 29.94%	591,704 $19.6 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $4.13 Million - $4.78 Million	114,317 Added 15.66%	844,530 $31 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $3.22 Million - $4.19 Million	81,639 Added 12.59%	730,213 $29.8 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $397,877 - $519,385	9,530 Added 1.49%	648,574 $31.1 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $2.23 Million - $2.73 Million	-51,069 Reduced 7.4%	639,044 $28 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $157,271 - $186,474	-3,380 Reduced 0.49%	690,113 $36.2 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $31.7 Million - $39.3 Million	693,493 New	693,493 $35.9 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $20.4 Million - $30.3 Million	-494,314 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $944,669 - $1.21 Million	24,068 Added 5.12%	494,314 $21.3 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $353,426 - $400,372	-9,842 Reduced 2.05%	470,246 $18.4 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $2.48 Million - $2.8 Million	74,062 Added 18.24%	480,088 $17.4 Million
Q4 2020 Feb 22, 2021	BUY	$33.47 - $42.56 $1.22 Million - $1.55 Million	36,526 Added 9.89%	406,026 $14.9 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $11.7 Million - $13.8 Million	369,500 New	369,500 $13.6 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $12.2 Million - $17.4 Million	-449,911 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $4.77 Million - $5.42 Million	-144,980 Reduced 24.37%	449,911 $17.6 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $7.78 Million - $10.1 Million	-239,564 Reduced 28.71%	594,891 $21.4 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $2.3 Million - $2.58 Million	-62,234 Reduced 6.94%	834,455 $36.1 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.45 Million - $1.59 Million	-38,647 Reduced 4.13%	896,689 $38.1 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $122,719 - $139,913	3,190 Added 0.34%	935,336 $40.8 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $6.36 Million - $7.72 Million	-184,609 Reduced 16.53%	932,146 $41.1 Million
Q2 2018 Jul 27, 2018	BUY	$32.98 - $35.16 $2.03 Million - $2.16 Million	61,499 Added 5.83%	1,116,755 $40.5 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $2.88 Million - $3.34 Million	90,115 Added 9.34%	1,055,256 $37.4 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $15.1 Million - $16 Million	453,342 Added 88.58%	965,141 $35 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $343,077 - $377,938	11,067 Added 2.21%	511,799 $18.3 Million
Q2 2017 Aug 29, 2017	BUY	N/A	500,732	500,732 $16.8 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Pfizer Inc Transaction History